A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

Completed · Phase 3

Conditions studied: Acute Lymphoblastic Leukemia

In brief

This study will compare the efficacy, in terms of complete responses and overall survival, of inotuzumab ozogamicin versus investigator's choice of chemotherapy.

Key facts

Study ID

NCT01564784

Run by

Pfizer

People needed

326

Starts

2012-08-02

Expected to finish

2017-01-04

Last updated by the study team

2019-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• CD22 expression
• Adequate liver and renal functions

You may not qualify if…

• Isolated extramedullary disease
• Active Central Nervous System [CNS] disease

Where it is running

• UC San Diego Medical Center - La Jolla — La Jolla, California, United States
• UC San Diego Moores Cancer Center — La Jolla, California, United States
• Children's Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles — Los Angeles, California, United States
• Keck Hospital of USC — Los Angeles, California, United States
• LAC+USC Medical Center — Los Angeles, California, United States
• USC Norris Comprehensive Cancer Center — Los Angeles, California, United States
• USC/Norris Comprehensive Cancer Center / Investigational Drug Services — Los Angeles, California, United States
• USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
• UCLA Drug Information/Investigation Drug — Los Angeles, California, United States
• UCLA Hematology/Oncology Clinic — Los Angeles, California, United States
• UCLA Ronald Reagan Medical Center — Los Angeles, California, United States
• UCLA Rrmc — Los Angeles, California, United States
• UC Irvine Medical Center — Orange, California, United States
• Children's Hospital of Orange County — Orange, California, United States
• UC Irvine Medical Center — Orange, California, United States
• Freidenrich Center for Translational Research (CTRU), Stanford University — Palo Alto, California, United States
• UC San Diego Medical Center - Hillcrest — San Diego, California, United States
• Martha Hamilton, Investigational Drug Services, Dept of Pharmacy — Stanford, California, United States
• Stanford Cancer Institute — Stanford, California, United States
• Stanford University Hospital and Clinics — Stanford, California, United States
• University of Colorado Cancer Center — Aurora, Colorado, United States
• University of Colorado Hospital, Cancer Center Infusion Center — Aurora, Colorado, United States
• University of Colorado Hospital — Aurora, Colorado, United States
• Yale-New Haven Hospital & Smilow Cancer Center — New Haven, Connecticut, United States
• Investigational Drug Services - UC San Diego Moores Cancer Center — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.